Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma
- 1 April 2001
- Vol. 91 (7) , 1264-1271
- https://doi.org/10.1002/1097-0142(20010401)91:7<1264::aid-cncr1127>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced CancerJournal of Clinical Oncology, 2000
- Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal CancerJournal of Clinical Oncology, 2000
- Raltitrexed (‘Tomudex’) and oxaliplatin: an active out-patient regimen in malignant mesotheliomaEuropean Journal Of Cancer, 1999
- Advanced colorectal cancer: Which regimes should we recommend?Annals of Oncology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Overview of the tolerability of ??Tomudex?? (raltitrexed): collective clinical experience in advanced colorectal cancerAnti-Cancer Drugs, 1997
- ‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopeniaEuropean Journal Of Cancer, 1995
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958